Skip to main content
. 2022 Sep 3;19(17):11051. doi: 10.3390/ijerph191711051
ARVs Antiretrovirals
CDC U.S. Center for Disease Control and Prevention
CKD Chronic Kidney Disease
CYPs Cytochromes P450
DBP Diastolic Blood Pressure
EsMoH Eswatini Ministry of Health
HAART Highly Active Antiretroviral Therapy
INH Isonicotinylhydrazide (Isoniazid)
IQR Interquartile Range
LFTs Liver Function Tests
MDRD Modification of Diet in Renal Disease
NICE National Institute for Health and Care Excellence
NNRTIs Non-nucleoside Reverse Transcriptase Inhibitors
NRTIs Nucleoside Reverse Transcriptase Inhibitors
PAGAA Panel on Antiretroviral Guidelines for Adults and Adolescents
PAHO Pan American Health Organization
PEPFAR President’s Emergency Plan for AIDS Relief
PIs Protease Inhibitors
PLHIV People Living with HIV
RFMH Raleigh Fitkin Memorial Hospital
SBP Systolic Blood Pressure
SHIMS Swaziland HIV Incidence Measurement Survey
SNAP Eswatini National Program
USAID United States Agency for International Development
USDHHS United States Department of Health of Human Services